HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Autosomal Dominant 28 Deafness

mutation in ESRRB

Also Known As:

Deafness, Autosomal Dominant 28; DFNA28

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Hearing Loss (Hearing Impairment)
2.	Deafness (Deaf Mutism)
3.	Autosomal Dominant 10 Deafness

Experts

1.	Bae, Seung-Hyun: 1 article (01/2015)
2.	Choi, Jae Young: 1 article (01/2015)
3.	Kim, Hyung-Jong: 1 article (01/2015)
4.	Kim, Min-A: 1 article (01/2015)
5.	Kim, Un-Kyung: 1 article (01/2015)
6.	Kim, Ye-Ri: 1 article (01/2015)
7.	Lee, Hyo-Jeong: 1 article (01/2015)
8.	Lee, Kyu-Yup: 1 article (01/2015)
9.	Sagong, Borum: 1 article (01/2015)
10.	Du, Jiulin: 1 article (08/2011)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Autosomal Dominant 28 Deafness:

1.	Transcription Factors (Transcription Factor)IBA 01/01/2023 - "Mutations in the transcription factor gene grainyhead-like 2 (GRHL2) are associated with progressive non-syndromic sensorineural deafness autosomal dominant type 28 (DFNA28) in humans. " 01/01/2015 - "Since EYA4 and GRHL2 were identified as the transcription factors for the DFNA10 and DFNA28, 8 EYA4 mutations and 2 GRHL2 mutations have been reported worldwide. " 11/01/2002 - "Mutation of a transcription factor, TFCP2L3, causes progressive autosomal dominant hearing loss, DFNA28."
2.	Messenger RNA (mRNA)IBA 08/15/2011 - "Injection of human wild-type GRHL2 mRNA but not the mutant GRHL2 mRNA derived from DFNA28 patients into grhl2b(T086) mutant embryos could rescue the inner-ear defects. "